In addition, we believe that this study provides important preliminary evidence that IFN may be effective in inducing and maintaining remission in severe EGPA making it superior to standard immunosuppression which is often limited by poor efficacy or toxicity. This evidence concerns the gene IFNA1 and eosinophilic granulomatosis with polyangiitis.